PHL-FENOFIBRATE SUPRA DIN 02251663
Health Canada record
| Active ingredient(s) | FENOFIBRATE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AB05 FENOFIBRATE |
| Original market date | |
| Current status date | 13-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmel Inc. — licence 101409, not currently licensed, last inspection rating C (2018-01-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FENOFIBRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02243180 | AA-FENO-MICRO | AA PHARMA INC | Capsule | FENOFIBRATE 67 MG | Marketed |
| 02239864 | AA-FENO-MICRO | AA PHARMA INC | Capsule | FENOFIBRATE 200 MG | Marketed |
| 02246859 | AA-FENO-SUPER | AA PHARMA INC | Tablet | FENOFIBRATE 100 MG | Marketed |
| 02246861 | AA-FENO-SUPER | AA PHARMA INC | Tablet | FENOFIBRATE 200 MG | Approved |
| 02246860 | AA-FENO-SUPER | AA PHARMA INC | Tablet | FENOFIBRATE 160 MG | Marketed |
| 02223600 | FENOFIBRATE | APOTEX INC | Capsule | FENOFIBRATE 100 MG | Approved |
| 02564246 | JAMP FENOFIBRATE E | JAMP PHARMA CORPORATION | Tablet | FENOFIBRATE 145 MG | Approved |
| 02564238 | JAMP FENOFIBRATE E | JAMP PHARMA CORPORATION | Tablet | FENOFIBRATE 48 MG | Approved |
| 02269082 | LIPIDIL EZ | BGP PHARMA ULC | Tablet | FENOFIBRATE 145 MG | Marketed |
| 02269074 | LIPIDIL EZ | BGP PHARMA ULC | Tablet | FENOFIBRATE 48 MG | Marketed |
| 02241602 | LIPIDIL SUPRA | BGP PHARMA ULC | Tablet | FENOFIBRATE 160 MG | Marketed |
| 02231496 | PMS-FENOFIBRATE | PHARMASCIENCE INC | Capsule | FENOFIBRATE 100 MG | Approved |
| 02251736 | PMS-FENOFIBRATE SUPRA | PHARMASCIENCE INC | Tablet | FENOFIBRATE 160 MG | Approved |
| 02251728 | PMS-FENOFIBRATE SUPRA | PHARMASCIENCE INC | Tablet | FENOFIBRATE 100 MG | Approved |
| 02391309 | RAN-FENOFIBRATE S | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | FENOFIBRATE 100 MG | Approved |
| 02391317 | RAN-FENOFIBRATE S | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | FENOFIBRATE 160 MG | Approved |
| 02390698 | SANDOZ FENOFIBRATE E | SANDOZ CANADA INCORPORATED | Tablet | FENOFIBRATE 48.0 MG | Marketed |
| 02390701 | SANDOZ FENOFIBRATE E | SANDOZ CANADA INCORPORATED | Tablet | FENOFIBRATE 145.0 MG | Marketed |
| 02454696 | SPC-FENOFIBRATE E | SUN PHARMA CANADA INC | Tablet | FENOFIBRATE 145 MG | Marketed |
| 02364409 | AVA-FENOFIBRATE MICRO | AVANSTRA INC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02240337 | DOM-FENOFIBRATE MICRO | DOMINION PHARMACAL | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02251701 | DOM-FENOFIBRATE SUPRA | DOMINION PHARMACAL | Tablet | FENOFIBRATE 160 MG | Cancelled Pre Market |
| 02251698 | DOM-FENOFIBRATE SUPRA | DOMINION PHARMACAL | Tablet | FENOFIBRATE 100 MG | Cancelled Pre Market |
| 02240360 | FENO-MICRO-200 | PRO DOC LIMITEE | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02225980 | FENOFIBRATE | AA PHARMA INC | Capsule | FENOFIBRATE 100 MG | Dormant |
| 02286092 | FENOFIBRATE MICRO | SANIS HEALTH INC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02356570 | FENOFIBRATE-S | SANIS HEALTH INC | Tablet | FENOFIBRATE 100 MG | Cancelled Post Market |
| 02356589 | FENOFIBRATE-S | SANIS HEALTH INC | Tablet | FENOFIBRATE 160 MG | Cancelled Post Market |
| 02250004 | FENOMAX | CIPHER PHARMACEUTICALS INC | Capsule | FENOFIBRATE 160 MG | Cancelled Post Market |
| 02249995 | FENOMAX | CIPHER PHARMACEUTICALS INC | Capsule | FENOFIBRATE 100 MG | Cancelled Pre Market |
| 00885827 | LIPIDIL CAP 100MG | LABORATOIRES FOURNIER S.A.S. | Capsule | FENOFIBRATE 100 MG | Cancelled Post Market |
| 02146959 | LIPIDIL MICRO | BGP PHARMA ULC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02230283 | LIPIDIL MICRO - CAP 67MG | LABORATOIRES FOURNIER S.A.S. | Capsule | FENOFIBRATE 67 MG | Cancelled Post Market |
| 02241601 | LIPIDIL SUPRA 100 MG | LABORATOIRES FOURNIER S.A.S. | Tablet | FENOFIBRATE 100 MG | Cancelled Post Market |
| 02465167 | MINT-FENOFIBRATE E | MINT PHARMACEUTICALS INC | Tablet | FENOFIBRATE 145 MG | Cancelled Post Market |
| 02240210 | MYLAN-FENOFIBRATE MICRO | MYLAN PHARMACEUTICALS ULC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02231495 | NOVO-FENOFIBRATE | NOVOPHARM LIMITED | Capsule | FENOFIBRATE 100 MG | Cancelled Post Market |
| 02243551 | NOVO-FENOFIBRATE MICRONIZED | NOVOPHARM LIMITED | Capsule | FENOFIBRATE 67 MG | Cancelled Post Market |
| 02243552 | NOVO-FENOFIBRATE MICRONIZED | NOVOPHARM LIMITED | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02352389 | NTP-FENOFIBRATE-S | TEVA CANADA LIMITED | Tablet | FENOFIBRATE 160 MG | Cancelled Pre Market |
| 02352370 | NTP-FENOFIBRATE-S | TEVA CANADA LIMITED | Tablet | FENOFIBRATE 100 MG | Cancelled Pre Market |
| 02335875 | NU-FENO-MICRO | NU-PHARM INC | Capsule | FENOFIBRATE 67 MG | Cancelled (Unreturned Annual) |
| 02249715 | NU-FENO-MICRO | NU-PHARM INC | Capsule | FENOFIBRATE 200 MG | Cancelled (Unreturned Annual) |
| 02247489 | PHL-FENOFIBRATE MICRO | PHARMEL INC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02251671 | PHL-FENOFIBRATE SUPRA | PHARMEL INC | Tablet | FENOFIBRATE 160 MG | Cancelled Pre Market |
| 02231780 | PMS-FENOFIBRATE MICRO | PHARMASCIENCE INC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02273551 | PMS-FENOFIBRATE MICRO | PHARMASCIENCE INC | Capsule | FENOFIBRATE 200 MG | Dormant |
| 02310228 | PRO-FENO-SUPER - 100 | PRO DOC LIMITEE | Tablet | FENOFIBRATE 100 MG | Cancelled Post Market |
| 02310236 | PRO-FENO-SUPER - 160 | PRO DOC LIMITEE | Tablet | FENOFIBRATE 160 MG | Cancelled Post Market |
| 02371405 | Q-FENOFIBRATE MICRO | QD PHARMACEUTICALS ULC | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02250039 | RATIO-FENOFIBRATE MC | TEVA CANADA LIMITED | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02247306 | RIVA-FENOFIBRATE MICRO | LABORATOIRE RIVA INC. | Capsule | FENOFIBRATE 200 MG | Cancelled Post Market |
| 02288044 | SANDOZ FENOFIBRATE S | SANDOZ CANADA INCORPORATED | Tablet | FENOFIBRATE 100 MG | Cancelled Post Market |
| 02288060 | SANDOZ FENOFIBRATE S | SANDOZ CANADA INCORPORATED | Tablet | FENOFIBRATE 200 MG | Cancelled Pre Market |
| 02288052 | SANDOZ FENOFIBRATE S | SANDOZ CANADA INCORPORATED | Tablet | FENOFIBRATE 160 MG | Cancelled Post Market |
| 02289091 | TEVA-FENOFIBRATE-S | TEVA CANADA LIMITED | Tablet | FENOFIBRATE 160 MG | Cancelled Post Market |
| 02289083 | TEVA-FENOFIBRATE-S | TEVA CANADA LIMITED | Tablet | FENOFIBRATE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6174 | 2005-01-12 | Supplement to a New Drug Submission (SNDS) | NEW DOSAGE FORM |
International API supply for FENOFIBRATE
15 valid EDQM Certificates of Suitability from 14 holders. 25 active FDA Drug Master Files.
Request a quote for PHL-FENOFIBRATE SUPRA